Medtronic Raises FY24 Adjusted EPS Guidance To $5.13-$5.19 From Prior Guidance Of $5.08-$5.16 Versus Consensus Of $5.13
Portfolio Pulse from Benzinga Newsdesk
Medtronic has increased its FY24 adjusted EPS guidance to a range of $5.13-$5.19, up from the previous range of $5.08-$5.16. This new guidance is in line with the consensus estimate of $5.13.
November 21, 2023 | 11:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic has raised its FY24 adjusted EPS guidance, which could positively influence investor sentiment and potentially lead to a short-term increase in stock price.
Raising EPS guidance typically indicates a company's confidence in its financial performance and future prospects. This update from Medtronic aligns with consensus estimates, which may reassure investors and could lead to a positive short-term reaction in the stock market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100